The Willans’ group main research field of interest is in the development of novel N-heterocyclic carbene (NHC) ligands with a view to stabilising metal intermediates during catalysis and driving the field of metal-NHCs in cancer therapy. ┬áNovel synthetic methods to metal-NHCs are also being developed within the group, with the aim of making these complexes more attractive for wide scale-use. In addition, innovative electrochemical technology has been designed and built in collaboration with engineers at the University of Leeds.
Willans Research Group